drugset / Trial / NCT00058448
S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)
Phase 2
Terminated
1 enrolled
SWOG Cancer Research Network
Eastern Cooperative Oncology Group · collabNational Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy such as docetaxel use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating patients who have locally advanced or metastatic penile cancer.
Timeline
- Start
- 2004-10
- Primary completion
- 2005-11
- Completion
- 2005-11
Outcome
Outcome not reported
Stopped (Enrollment): “Study terminated due to poor patient recruitment.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | Intravenous |